Sam-A Pharm. Co. Ltd Logo

Sam-A Pharm. Co. Ltd

009300 | KO

Overview

Corporate Details

ISIN(s):
KR7009300005
LEI:
Country:
South Korea
Address:
강원도 원주시 문막읍 동화공단로 49, 원주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-25 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 30.7 KB
2025-08-25 00:00
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 39.1 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 998.7 KB
2025-05-15 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 1009.9 KB
2025-05-13 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 993.0 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-03-28 00:00
AGM Information
정기주주총회결과
Korean 24.4 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.5 MB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 24.5 KB
2025-03-17 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 110.0 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 112.4 KB
2025-02-28 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.2 KB
2025-02-28 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.1 KB
2025-02-26 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.5 KB
2024-12-10 00:00
Quarterly Report
[기재정정]분기보고서 (2024.09)
Korean 902.6 KB

Automate Your Workflow. Get a real-time feed of all Sam-A Pharm. Co. Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sam-A Pharm. Co. Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sam-A Pharm. Co. Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America
PRPH
Protagonist Therapeutics, Inc Logo
Develops peptide therapeutics for blood disorders and inflammatory or immunomodulatory diseases.
United States of America
PTGX
Protalix BioTherapeutics, Inc. Logo
Develops plant-cell-based protein therapies for rare diseases like Gaucher and Fabry.
United States of America
PLX
PROTIA INC. Logo
Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.
South Korea
303360
PSYENCE BIOMEDICAL LTD. Logo
Developing natural psilocybin therapies for anxiety and depression in palliative care.
United States of America
PBM
PTC THERAPEUTICS, INC. Logo
Develops and commercializes pioneering medicines for patients with rare diseases.
United States of America
PTCT
Pulmatrix, Inc. Logo
Develops inhaled therapies for respiratory and CNS disorders using its iSPERSE™ technology.
United States of America
PULM
PUMA BIOTECHNOLOGY, INC. Logo
Develops and commercializes innovative cancer therapeutics, with an approved drug and a clinical pipeline.
United States of America
PBYI
Pure Biologics S.A. Logo
Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.
Poland
PUR
PureTech Health plc Logo
A clinical-stage biotherapeutics firm developing new medicines for devastating diseases.
United States of America
PRTC

Talk to a Data Expert

Have a question? We'll get back to you promptly.